Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

8.27
Delayed Data
As of Aug 28
 +0.79 / +10.56%
Today’s Change
6.23
Today|||52-Week Range
25.60
-48.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues13.8M12.7M19.6M7.7M
 
 
 
 
 
Depreciation And Amortization911.0K1.0M1.4M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.0M24.3M36.0M51.1M
 
 
 
 
 
Research And Development17.3M20.3M29.9M41.0M
 
 
 
 
 
Total Operating Expenses20.9M25.3M37.4M52.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.1M-12.6M-17.8M-44.9M
 
 
 
 
 
Extraordinary Charge0.00-4.7M-1.1M-12.1M
 
 
 
 
Interest Expense On Debt388.0K247.0K36.0K39.0K
 
 
 
 
 
Other Expenses1.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.4M-17.4M-18.7M-56.7M
 
 
 
 
 
Income Taxes-206.0K-10.0K-23.0K-1.0K
 
 
 
 
 
Net Income-7.4M-17.4M-18.7M-56.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.1M8.2M38.5M44.1M
 
 
 
 
 
Shares To Calculate EPS Diluted34.1M8.2M38.5M44.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$2.12-$0.49-$1.29
 
 
 
 
 
EPS Diluted-$0.22-$2.12-$0.49-$1.29